Article Information
History
- July 28, 2021.
Article Versions
- Version 1 (July 10, 2021 - 17:57).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Nguyen Van Vinh Chau1,#,
- Lam Anh Nguyet2,
- Nguyen Thanh Truong1,
- Le Mau Toan1,
- Nguyen Thanh Dung1,
- Le Manh Hung1,
- Mai Thanh Nhan1,
- Dinh Nguyen Huy Man1,
- Nghiem My Ngoc1,
- Huynh Phuong Thao1,
- Tran Nguyen Hoang Tu1,
- Huynh Kim Mai3,
- Do Thai Hung3,
- Nguyen Thi Han Ny2,
- Le Kim Thanh2,
- Nguyen To Anh2,
- Nguyen Thi Thu Hong2,
- Le Nguyen Truc Nhu2,
- Lam Minh Yen2,
- Marc Choisy2,4,
- Tran Tan Thanh2,
- Guy Thwaites2,3,
- Le Van Tan2,#,
- OUCRU COVID-19 Research Group*
- 1Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam
- 2Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam
- 3Institute of Pasteur, Nha Trang City, Vietnam
- 4Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK
- ↵#Correspondence: Nguyen Van Vinh Chau, chaunvv{at}oucru.org, Le Van Tan, tanlv{at}oucru.org
Posted July 28, 2021.
Immunogenicity of Oxford-AstraZeneca COVID-19 vaccine in Vietnamese healthcare workers
